Orient EuroPharma Co., Ltd. (TPEX: 4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,456	1,736	1,801	1,959	2,121	1,752
Short-Term Investments	90.3	365.97	70.8	80.8	201.8	81.8
Cash & Short-Term Investments	1,546	2,102	1,872	2,040	2,323	1,834
Cash Growth	-23.21%	12.30%	-8.25%	-12.19%	26.68%	-4.61%
Accounts Receivable	788.27	783.01	730.48	580.03	524.06	703.03
Other Receivables	18.52	26.94	27.66	33.53	18.17	20.93
Receivables	806.8	809.94	758.15	613.55	542.23	723.96
Inventory	1,108	1,147	1,304	1,082	1,350	1,478
Prepaid Expenses	139.19	118.23	162.21	136.07	87.96	142.99
Other Current Assets	284.56	50.83	88.62	53.63	13.89	6.24
Total Current Assets	3,884	4,228	4,185	3,925	4,317	4,185
Property, Plant & Equipment	3,882	3,986	4,019	4,181	2,894	2,827
Long-Term Investments	3,088	1,064	533.57	416.83	191.06	145.7
Other Intangible Assets	41.9	42.69	43.01	78.16	104.48	123.98
Long-Term Deferred Tax Assets	647.96	677.16	588.05	631.87	522.46	507.06
Other Long-Term Assets	783.51	814.28	1,062	170.82	130.57	83.5
Total Assets	12,328	10,812	10,430	9,403	8,160	7,873
Accounts Payable	180.55	348.07	552.2	159.81	318.76	334.4
Accrued Expenses	268.33	280.31	353.04	390.66	456.17	429.59
Short-Term Debt	2,729	2,324	2,191	2,050	1,225	1,195
Current Portion of Long-Term Debt	449.8	272.31	350.18	246.82	158.57	91.53
Current Portion of Leases	38.38	41.95	44.06	25.78	32.41	31.34
Current Income Taxes Payable	25.43	138.39	16.02	55.52	13.76	56.1
Current Unearned Revenue	-	-	-	-	-	99.28
Other Current Liabilities	254.16	307.18	286.42	303.12	224.54	178.5
Total Current Liabilities	3,946	3,712	3,793	3,232	2,429	2,416
Long-Term Debt	1,396	1,790	1,991	1,680	758.28	617.48
Long-Term Leases	361.34	412.89	447.92	218.46	229.47	233.59
Long-Term Deferred Tax Liabilities	677	651.99	671.26	728.29	746.01	692.84
Other Long-Term Liabilities	23.22	23.44	23.3	24.65	26.83	27.2
Total Liabilities	6,450	6,649	6,987	5,950	4,255	4,061
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	271.26	271.26	271.26	263.44	260.77	246.84
Retained Earnings	1,445	1,752	1,738	2,118	2,274	2,174
Comprehensive Income & Other	2,637	624.12	51.9	-307.04	-193.43	-93.67
Total Common Equity	5,221	3,514	2,929	2,942	3,209	3,195
Minority Interest	656.32	648	514.77	511.39	696.34	617.18
Shareholders' Equity	5,878	4,162	3,444	3,453	3,905	3,812
Total Liabilities & Equity	12,328	10,812	10,430	9,403	8,160	7,873
Total Debt	4,975	4,841	5,024	4,221	2,403	2,169
Net Cash (Debt)	-3,429	-2,739	-3,153	-2,181	-80.19	-335.07
Net Cash Per Share	-39.44	-31.50	-36.34	-25.08	-0.92	-3.85
Filing Date Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Working Capital	-61.59	515.42	391.79	693.29	1,888	1,769
Book Value Per Share	60.19	40.51	33.76	33.91	36.99	36.83
Tangible Book Value	5,179	3,472	2,886	2,864	3,104	3,071
Tangible Book Value Per Share	59.71	40.02	33.27	33.01	35.78	35.40
Land	1,171	1,169	1,169	1,462	578.12	438.37
Buildings	2,361	2,347	2,243	2,190	1,754	1,739
Machinery	1,092	1,069	992.9	965.5	918.07	933.79
Construction In Progress	3.62	3.55	36.12	48.41	0.88	10.73

Source: S&P Capital IQ. Standard template. Financial Sources.